Evidence map›Paper›PMID 28041957›Full record

ArticleCell metabolism2017

Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks.

Ildem Akerman, Zhidong Tu, Anthony Beucher, Delphine M Y Rolando, Claire Sauty-Colace, Marion Benazra, Nikolina Nakic, Jialiang Yang, Huan Wang, Lorenzo Pasquali and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Cell metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed, 2 pooled it
19.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 2 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The Role of Long Intergenic Noncoding RNA in Fetal Development.International journal of molecular sciences · 2024
    Review
  17. Review
  18. Review
  19. Review
  20. Puzzling out the role ofNon-coding RNA research · 2024
    Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 6 countries.

Ildem AkermanSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom; Genomic Programming of Beta Cells Laboratory, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona 08036, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid 28029, Spain.
Zhidong TuDepartment of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Anthony BeucherSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Delphine M Y RolandoSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Claire Sauty-ColaceSorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut du cerveau et de la moelle (ICM) - Hôpital Pitié-Salpêtrière, Boulevard de l'Hôpital, Paris 75013, France.
Marion BenazraSorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut du cerveau et de la moelle (ICM) - Hôpital Pitié-Salpêtrière, Boulevard de l'Hôpital, Paris 75013, France.
Nikolina NakicSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Jialiang YangDepartment of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Huan WangDepartment of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Lorenzo PasqualiCentro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid 28029, Spain; Germans Trias i Pujol University Hospital and Research Institute and Josep Carreras Leukaemia Research Institute, Badalona 08916, Spain.
Ignasi MoranSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Javier Garcia-HurtadoGenomic Programming of Beta Cells Laboratory, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona 08036, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid 28029, Spain.
Natalia CastroGenomic Programming of Beta Cells Laboratory, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona 08036, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid 28029, Spain.
Roser Gonzalez-FrancoSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom.
Andrew F StewartDiabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Caroline BonnerEuropean Genomic Institute for Diabetes, INSERM UMR 1190, Lille 59800, France.
Lorenzo PiemontiDiabetes Research Institute (HSR-DRI), San Raffaele Scientific Institute, Milano 20132, Italy.
Thierry BerneyCell Isolation and Transplantation Center, University of Geneva, 1211 Geneva 4, Switzerland.
Leif GroopDepartment of Clinical Sciences, Lund University Diabetes Centre, Lund University, Lund 20502, Sweden.
Julie Kerr-ConteEuropean Genomic Institute for Diabetes, INSERM UMR 1190, Lille 59800, France.
Francois PattouEuropean Genomic Institute for Diabetes, INSERM UMR 1190, Lille 59800, France.
Carmen ArgmannDepartment of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Eric SchadtDepartment of Genetics and Genomic Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Philippe RavassardSorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut du cerveau et de la moelle (ICM) - Hôpital Pitié-Salpêtrière, Boulevard de l'Hôpital, Paris 75013, France.
Jorge FerrerSection of Epigenomics and Disease, Department of Medicine, Imperial College London, London W12 0NN, United Kingdom; Genomic Programming of Beta Cells Laboratory, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona 08036, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid 28029, Spain. Electronic address: jferrerm@imperial.ac.uk.
Icahn School of Medicine at Mount Sinai · USImperial College London · GBConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESInserm · FRInstitut du Cerveau · FREuropean Genomic Institute for Diabetes · FRLund University · SESorbonne Université · FRUniversity of Geneva · CH

Funding

Coordinating Center for Beta Cell Biology ConsortiumU01DK072473 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2005 to 2014
$61.0M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
NIDDK NIH HHS P30 DK020541NIDDK NIH HHS U01 DK072473NIH HHS S10 OD018522Wellcome Trust WT101033
6 · The paper itself

Abstract

Recent studies have uncovered thousands of long non-coding RNAs (lncRNAs) in human pancreatic β cells. β cell lncRNAs are often cell type specific and exhibit dynamic regulation during differentiation or upon changing glucose concentrations. Although these features hint at a role of lncRNAs in β cell gene regulation and diabetes, the function of β cell lncRNAs remains largely unknown. In this study, we investigated the function of β cell-specific lncRNAs and transcription factors using transcript knockdowns and co-expression network analysis. This revealed lncRNAs that function in concert with transcription factors to regulate β cell-specific transcriptional networks. We further demonstrate that the lncRNA PLUTO affects local 3D chromatin structure and transcription of PDX1, encoding a key β cell transcription factor, and that both PLUTO and PDX1 are downregulated in islets from donors with type 2 diabetes or impaired glucose tolerance. These results implicate lncRNAs in the regulation of β cell-specific transcription factor networks.

Indexed as

ChromatinDiabetes Mellitus, Type 2Gene Expression RegulationGene Knockdown TechniquesGene Regulatory NetworksHomeodomain ProteinsHumansInsulinInsulin-Secreting CellsInsulin SecretionMultigene FamilyPhenotypeRNA, Long NoncodingRNA, MessengerTrans-ActivatorsTranscription FactorsChromatinHomeodomain ProteinsInsulinpancreatic and duodenal homeobox 1 proteinRNA, Long NoncodingRNA, MessengerTrans-ActivatorsTranscription FactorschromatinCRISPR interferencediabeteslncRNAslong noncoding RNAspancreatic isletsPDX1PLUTOtranscriptional networkstype 2 diabetes

Identifiers

PMID28041957
PMCPMC5300904
OpenAlexW2561206768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.